162 related articles for article (PubMed ID: 10756345)
21. Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects.
Abdel-Malak C; Darwish H; Elsaid A; El-Tarapely F; Elshazli R
Fam Cancer; 2016 Jan; 15(1):49-56. PubMed ID: 26314409
[TBL] [Abstract][Full Text] [Related]
22. Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect.
Rozen P; Naiman T; Strul H; Taussky P; Karminsky N; Shomrat R; Samuel Z; Yaron Y; Orr-Urtreger A
Cancer; 2002 May; 94(10):2561-8. PubMed ID: 12173321
[TBL] [Abstract][Full Text] [Related]
23. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.
Drucker L; Shpilberg O; Neumann A; Shapira J; Stackievicz R; Beyth Y; Yarkoni S
Cancer; 2000 Feb; 88(4):755-60. PubMed ID: 10679643
[TBL] [Abstract][Full Text] [Related]
24. No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.
Abrahamson J; Moslehi R; Vesprini D; Karlan B; Fishman D; Smotkin D; Ben David Y; Biran H; Fields A; Brunet JS; Narod SA
Cancer Res; 1998 Jul; 58(14):2919-22. PubMed ID: 9679945
[TBL] [Abstract][Full Text] [Related]
25. Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals.
Ukaegbu C; Levi Z; Fehlmann TD; Uno H; Chittenden A; Inra JA; Grover S; Kastrinos F; Syngal S; Yurgelun MB
Fam Cancer; 2021 Apr; 20(2):111-116. PubMed ID: 32743790
[TBL] [Abstract][Full Text] [Related]
26. Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients.
Lehrer S; McCurdy LD; Stock RG; Kornreich R; Stone NN; Eng C
Cancer Genet Cytogenet; 2000 Oct; 122(2):131-3. PubMed ID: 11106824
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases.
Figer A; Shtoyerman-Chen R; Tamir A; Geva R; Irmin L; Flex D; Theodor L; Sulkes A; Sadetzki S; Bar-Meir S; Friedman E
Br J Cancer; 2001 Nov; 85(9):1368-71. PubMed ID: 11720476
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.
Esplen MJ; Madlensky L; Aronson M; Rothenmund H; Gallinger S; Butler K; Toner B; Wong J; Manno M; McLaughlin J
Clin Genet; 2007 Nov; 72(5):394-401. PubMed ID: 17892499
[TBL] [Abstract][Full Text] [Related]
29. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T
Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496
[TBL] [Abstract][Full Text] [Related]
30. Attitudes toward colon cancer gene testing: factors predicting test uptake.
Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
[TBL] [Abstract][Full Text] [Related]
31. Somatic instability of the APC I1307K allele in colorectal neoplasia.
Gryfe R; Di Nicola N; Gallinger S; Redston M
Cancer Res; 1998 Sep; 58(18):4040-3. PubMed ID: 9751605
[TBL] [Abstract][Full Text] [Related]
32. I1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer.
Yuan ZQ; Kasprzak L; Gordon PH; Pinsky L; Foulkes WD
Clin Genet; 1998 Oct; 54(4):368-70. PubMed ID: 9831355
[TBL] [Abstract][Full Text] [Related]
33. The APC I1307K allele conveys a significant increased risk for cancer.
Leshno A; Shapira S; Liberman E; Kraus S; Sror M; Harlap-Gat A; Avivi D; Galazan L; David M; Maharshak N; Moanis S; Arber N; Moshkowitz M
Int J Cancer; 2016 Mar; 138(6):1361-7. PubMed ID: 26421687
[TBL] [Abstract][Full Text] [Related]
34. The characterization of somatic APC mutations in colonic adenomas and carcinomas in Ashkenazi Jews with the APC I1307K variant using linkage disequilibrium.
Zauber NP; Sabbath-Solitare M; Marotta SP; Bishop DT
J Pathol; 2003 Feb; 199(2):146-51. PubMed ID: 12533826
[TBL] [Abstract][Full Text] [Related]
35. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analyses of colon cancer in I1307K APC mutation carriers compared with noncarriers.
Fidder HH; Barshack I; Chen-Shtoyerman R; Onaca N; Goldberg I; Rath P; Theodor L; Bar-Meir S; Friedman E
Dig Dis Sci; 2003 Jun; 48(6):1102-5. PubMed ID: 12822869
[TBL] [Abstract][Full Text] [Related]
37. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
[TBL] [Abstract][Full Text] [Related]
38. APC I1307K and the risk of prostate cancer.
Poynter JN; Cooney KA; Bonner JD; White KA; Tomsho LP; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):468-73. PubMed ID: 16537703
[TBL] [Abstract][Full Text] [Related]
39. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing.
Riegert-Johnson DL; Johnson RA; Rabe KG; Wang L; Thomas B; Baudhuin LM; Thibodeau SN; Boardman LA
Genet Test; 2007; 11(4):361-5. PubMed ID: 18294051
[TBL] [Abstract][Full Text] [Related]
40. Low prevalence of the APC I1307K sequence in Jewish and non-Jewish patients with inflammatory bowel disease.
Yin J; Harpaz N; Souza RF; Zou T; Kong D; Wang S; Leytin AL; Medalie NS; Smolinski KN; Abraham JM; Fleisher AS; Meltzer SJ
Oncogene; 1999 Jul; 18(26):3902-4. PubMed ID: 10445854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
